Results

eNauka >  Results >  High Dose Imatinib Induction Therapy (800 mg/day, 6 Months) In Pre-Treated Chronic Phase CML Patients Improves Cytogenetic and Molecular Responses but Does Not Improve Overall and Progression Free Survival - Final Results of the CELSG Phase III CML11 "IST
Title: High Dose Imatinib Induction Therapy (800 mg/day, 6 Months) In Pre-Treated Chronic Phase CML Patients Improves Cytogenetic and Molecular Responses but Does Not Improve Overall and Progression Free Survival - Final Results of the CELSG Phase III CML11 "IST
Authors: Perzeri, Andreas L; ...; Bogdanovic, Andrija D  ; ...; (broj, koautora 20)
Issue Date: 2010
Publication: BLOOD
ISSN: 0006-4971 Blood Search Idenfier
Type: Conference Paper
Collation: vol. 116 br. 21 str. 934-935
WoS-ID: 000289662202494
URI: https://enauka.gov.rs/handle/123456789/799715
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
Mp. category will be shown later

Find the DOI

Google ScholarTM

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.